Institute of Genome Biology, Research Institute for Farm Animal Biology (FBN), 18196, Dummerstorf, Germany.
Cell Mol Life Sci. 2023 Aug 5;80(8):240. doi: 10.1007/s00018-023-04894-6.
The limited endogenous regenerative capacity of the human heart renders cardiovascular diseases a major health threat, thus motivating intense research on in vitro heart cell generation and cell replacement therapies. However, so far, in vitro-generated cardiomyocytes share a rather fetal phenotype, limiting their utility for drug testing and cell-based heart repair. Various strategies to foster cellular maturation provide some success, but fully matured cardiomyocytes are still to be achieved. Today, several hormones are recognized for their effects on cardiomyocyte proliferation, differentiation, and function. Here, we will discuss how the endocrine system impacts cardiomyocyte maturation. After detailing which features characterize a mature phenotype, we will contemplate hormones most promising to induce such a phenotype, the routes of their action, and experimental evidence for their significance in this process. Due to their pleiotropic effects, hormones might be not only valuable to improve in vitro heart cell generation but also beneficial for in vivo heart regeneration. Accordingly, we will also contemplate how the presented hormones might be exploited for hormone-based regenerative therapies.
人类心脏的内源性再生能力有限,这使得心血管疾病成为一个主要的健康威胁,因此激发了人们对体外心脏细胞生成和细胞替代疗法的强烈研究兴趣。然而,到目前为止,体外生成的心肌细胞具有相当的胎儿表型,限制了它们在药物测试和基于细胞的心脏修复中的应用。各种促进细胞成熟的策略取得了一定的成功,但仍有待实现完全成熟的心肌细胞。如今,有几种激素因其对心肌细胞增殖、分化和功能的影响而被认识。在这里,我们将讨论内分泌系统如何影响心肌细胞的成熟。在详细描述了成熟表型的特征之后,我们将探讨最有希望诱导这种表型的激素、它们的作用途径以及它们在这一过程中的重要性的实验证据。由于其多效性作用,激素不仅可能有助于改善体外心脏细胞的生成,而且对体内心脏再生也有益。因此,我们还将探讨如何利用所提出的激素进行基于激素的再生治疗。